• 
• 
• 
• 
• 

FDA News and Drug Updates

FDA News - August 2017

FDA News - June 2017

Cancer Drug Approvals: A Tale of 2 Views

FDA News - April 2017: Additional Items

Supportive Care

A Taxing Consequence: Taxane Acute Pain Syndrome

Mark L. Zangardi, PharmD, BCOP

Helping Adolescents and Young Adults Confront Mortality

Meg Barbor, MPH

The Emerging Conversation About Physician-Assisted Death

Meg Barbor, MPH

View All Supportive Care Articles

Breast Cancer

No Advantage to Dual HER2 Blockade in Early-Stage Breast Cancer

Adding a Second Anti-HER2 Agent Appears Beneficial in Women with Early-Stage, HER2-Positive Breast Cancer at High Risk for Recurrence

Pembrolizumab Continues to Show Durable Activity in Triple-Negative Breast Cancer

View All Breast Cancer Articles

Conference Correspondent

Centers for Disease Control and Prevention Guidelines on Opioid Use for Cancer Pain

Maintenance Chemotherapy After Hematopoietic Stem-Cell Transplantation

Graft-versus-Host Disease: Breakthroughs on the Horizon

View All Conference Correspondent Articles

Most Popular Articles

Left- vs Right-Sided Colon Cancers

Eric Van Cutsem, MD, PhD

Video Library - Colon Cancer

Enzalutamide in the Treatment of Patients with Metastatic Castrate-Resistant Prostate Cancer

Adegoke O. Adeniji, BPharm, PhD, David A. Kaland, PhD, Launa M.J. Lynch, PhD, Vicky M. Mody, PhD

JHOP Web Exclusives - Online First, Review Article

Chemotherapy Discharge Education Class Improves Patient Safety

Alice Goodman

TON - July 2017, Vol 10, No 4 - Best Practices

Treatment of Advanced Breast Cancer: A Clinical Pharmacy Perspective

Val R. Adams, PharmD, FCCP, BCOP, Allison R. Butts, PharmD, BCOP

July 2017, Supplement - Review of Ribociclib for Advanced Hormone Receptor–Positive Breast Cancer - Perspective